Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 USD | -2.53% | -2.54% | -6.92% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 35.32M 25.93M |
---|---|---|---|---|---|
Net income 2024 * | -18M -13.22M | Net income 2025 * | -23M -16.89M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.94
x | P/E ratio 2025 * |
-2.5
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.98% |
Latest transcript on Acasti Pharma Inc.
1 day | -2.53% | ||
1 week | -2.54% | ||
Current month | -3.24% | ||
1 month | -19.70% | ||
3 months | -18.48% | ||
6 months | +23.39% | ||
Current year | -6.92% |
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 21-07-31 |
Director of Finance/CFO | 52 | Jan. 04 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 23-05-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 23-10-09 |
Director/Board Member | - | 23-10-09 | |
Santosh Kottayil
BRD | Director/Board Member | - | 23-10-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 2.69 | -2.53% | 15,108 |
24-05-16 | 2.76 | +2.22% | 5,314 |
24-05-15 | 2.7 | -3.23% | 27,961 |
24-05-14 | 2.79 | +1.09% | 9,667 |
24-05-13 | 2.76 | 0.00% | 6,929 |
Delayed Quote Nasdaq, May 17, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.92% | 25.94M | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- ACST Stock